Drug Profile
Morphine/modafinil
Alternative Names: MGX-001Latest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator BTG
- Developer Victory Pharma
- Class Morphinans; Opioid analgesics; Sleep disorder therapies
- Mechanism of Action Alpha 1 adrenergic receptor agonists; Opioid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 14 Jun 2007 Phase-II development is ongoing